Recent Quotes

My Watchlist

Indicators

Markets:

Overview

News

Currencies

International

Treasuries

Amneal Pharmaceuticals, Inc. - Class A Common Stock (NQ:AMRX)

17.16 +0.24 (+1.45%)

Streaming Delayed Price Updated: 2:29 PM EDT, Jul 7, 2026 Add to My Watchlist

Price and Volume

Detailed Quote

Volume	799,719
Open	17.21
Bid (Size)	17.16 (700)
Ask (Size)	17.17 (1,000)
Prev. Close	16.92
Today's Range	16.88 - 17.42
52wk Range	7.665 - 17.86
Shares Outstanding	1,000
Dividend Yield	N/A

Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News

Generic Pharmaceuticals Stocks Q4 In Review: Amneal (NASDAQ:AMRX) Vs Peers

July 06, 2026

As the Q4 earnings season wraps, let’s dig into this quarter’s best and worst performers in the generic pharmaceuticals industry, including Amneal (NASDAQ:AM...

Via StockStory

1 Mooning Stock Worth Your Attention and 2 We Question

June 29, 2026

Exciting developments are taking place for the stocks in this article. They’ve all surged ahead of the broader market over the last month as catalysts such a...

Via StockStory

Performance

YTD	+35.6%	+35.6%
1 Month	+25.2%	+25.2%
3 Month	+39.0%	+39.0%
6 Month	+35.1%	+35.1%
1 Year	+104.1%	+104.1%

More News

1 Small-Cap Stock for Long-Term Investors and 2 We Find Risky

June 17, 2026

Via StockStory

3 Russell 2000 Stocks with Open Questions

June 10, 2026

Via StockStory

Amneal Pharmaceuticals Bets on Biosimilars, Patches to Power Next Growth Phase ↗

June 09, 2026

Via MarketBeat

Amneal Announces Full Study Population Interim Phase 4 ELEVATE-PD Results, Reinforcing Previously Reported Benefits of CREXONT® in Parkinson's Disease

June 05, 2026

From Amneal Pharmaceuticals LLC

Via GlobeNewswire

Why Amneal (AMRX) Stock Is Trading Up Today

June 04, 2026

Via StockStory

Amneal Announces U.S. FDA Approval of Romidepsin Injection Solution

June 04, 2026

From Amneal Pharmaceuticals LLC

Via GlobeNewswire

3 Profitable Stocks with Open Questions

June 04, 2026

Via StockStory

Amneal to Participate in Goldman Sachs 47th Annual Global Healthcare Conference 2026

June 01, 2026

From Amneal Pharmaceuticals LLC

Via GlobeNewswire

Q4 Earnings Highlights: Amneal (NASDAQ:AMRX) Vs The Rest Of The Generic Pharmaceuticals Stocks

May 26, 2026

Via StockStory

2 Reasons AMRX is Risky and 1 Stock to Buy Instead

May 12, 2026

Via StockStory

Amneal Reports First Quarter 2026 Financial Results

May 07, 2026

From Amneal Pharmaceuticals LLC

Via GlobeNewswire

Amneal (AMRX) Q3 2025 Earnings Call Transcript ↗

May 04, 2026

Via The Motley Fool

Amneal (AMRX) Q2 2025 Earnings Transcript ↗

May 04, 2026

Via The Motley Fool

1 Value Stock to Target This Week and 2 Facing Challenges

May 04, 2026

Via StockStory

Amneal (AMRX) Q1 2026 Earnings Transcript ↗

May 01, 2026

Via The Motley Fool

Amneal (AMRX) Q1 Earnings Report Preview: What To Look For

April 29, 2026

Via StockStory

Kashiv BioSciences Agrees to Be Acquired by Amneal Pharmaceuticals to Create a Fully Integrated Global Biosimilar Leader

April 22, 2026

From Kashiv BioSciences, LLC

Via Business Wire

Amneal Agrees to Acquire Kashiv BioSciences to Create Global Biosimilar Leader; Reports Strong Preliminary First Quarter 2026 Financial Results and Raises FY2026 Standalone Guidance

April 22, 2026

From Amneal Pharmaceuticals LLC

Via GlobeNewswire

Amneal Announces Additional Positive Interim Phase 4 ELEVATE-PD Results with CREXONT® for Parkinson’s Disease, Including Over 3 More Hours of Daily “Good On” Time When Switching from RYTARY®

April 20, 2026

From Amneal Pharmaceuticals LLC

Via GlobeNewswire

Bruker, Amneal, Amphastar Pharmaceuticals, Dentsply Sirona, and PacBio Stocks Trade Up, What You Need To Know

April 17, 2026

Via StockStory

Amneal Launches First Two Respiratory Metered-Dose Inhalation Products in the U.S.

April 14, 2026

From Amneal Pharmaceuticals LLC

Via GlobeNewswire

2 Cash-Producing Stocks to Research Further and 1 We Brush Off

April 13, 2026

Via StockStory

Amneal Launches Bimatoprost Ophthalmic Solution, 0.01%

April 09, 2026

From Amneal Pharmaceuticals LLC

Via GlobeNewswire

Frequently Asked Questions

Is Amneal Pharmaceuticals, Inc. - Class A Common Stock publicly traded?

Yes, Amneal Pharmaceuticals, Inc. - Class A Common Stock is publicly traded.

What exchange does Amneal Pharmaceuticals, Inc. - Class A Common Stock trade on?

Amneal Pharmaceuticals, Inc. - Class A Common Stock trades on the Nasdaq Stock Market

What is the ticker symbol for Amneal Pharmaceuticals, Inc. - Class A Common Stock?

The ticker symbol for Amneal Pharmaceuticals, Inc. - Class A Common Stock is AMRX on the Nasdaq Stock Market

What is the current price of Amneal Pharmaceuticals, Inc. - Class A Common Stock?

The current price of Amneal Pharmaceuticals, Inc. - Class A Common Stock is 17.16

When was Amneal Pharmaceuticals, Inc. - Class A Common Stock last traded?

The last trade of Amneal Pharmaceuticals, Inc. - Class A Common Stock was at 07/07/26 02:29 PM ET

What is the market capitalization of Amneal Pharmaceuticals, Inc. - Class A Common Stock?

The market capitalization of Amneal Pharmaceuticals, Inc. - Class A Common Stock is 17.16K

How many shares of Amneal Pharmaceuticals, Inc. - Class A Common Stock are outstanding?

Amneal Pharmaceuticals, Inc. - Class A Common Stock has 17K shares outstanding.

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.